NCT02717949 Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study Status TERMINATED Phase PHASE4
NCT02712775 Minocycline Administration During Human Liver Transplantation Status WITHDRAWN Phase PHASE4
NCT02710266 Evaluation of the Effect of Gabexate Mesilate in the Hepatocyte Protection After Liver Resection Status TERMINATED Phase PHASE3
NCT02523196 Correlation and Comparison of the HepQuant® Disease Severity Index (DSI) With Hepatic Venous Pressure Gradient (HVPG) Status COMPLETED Phase PHASE3
NCT02520609 Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease Status COMPLETED Phase N/A
NCT02506335 Liver Function Measured by HepQuant-SHUNT in the Prediction of Outcomes in Patients With Heart Disease Status COMPLETED Phase EARLY_PHASE1
NCT02452177 Preventive and Reversional Effect of Vitamin D on Parenteral Nutrition Associated Liver Disease Status UNKNOWN Phase NA
NCT02420496 Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants Status WITHDRAWN Phase PHASE2
NCT02366845 Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease Status COMPLETED Phase PHASE4
NCT02329821 Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection Status COMPLETED Phase N/A
NCT02311348 Comparing Pain in Patients Undergoing Percutaneous Versus Transjugular Techniques of Liver Biopsy Status COMPLETED Phase N/A
NCT02306018 Evaluation of EV1000™/volumeView™ for Cardiac Output Monitoring in Liver Transplantation Status COMPLETED Phase N/A
NCT02209675 Role of Tissue C4d in Differentiation Between Acut e Rejection and HCV Recurrence After Liver Transplantation Status COMPLETED Phase NA